This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: University of Colorado. Active years: 2011-2019.
Company Filing History:
Years Active: 2011-2019
Title: Innovations by Phillip J Sanchez
Introduction
Phillip J Sanchez is a notable inventor based in Centennial, CO (US). He has made significant contributions to the field of immunology, particularly in the development of novel therapeutic approaches. With a total of 5 patents to his name, Sanchez's work focuses on enhancing immune responses to chronic diseases.
Latest Patents
Sanchez's latest patents include a nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I interferon. This innovative adjuvant comprises synergistically effective amounts of at least one type 1 interferon and at least one CD40 agonist. These components may be combined in the same or separate compositions. Additionally, he has developed fusion proteins and DNA conjugates that contain a type 1 interferon/CD40 agonist/antigen combination. The applications of these compositions, protein, and DNA conjugates serve as immune adjuvants for treating various chronic diseases, such as HIV infection, and for enhancing the efficacy of both prophylactic and therapeutic vaccines.
Career Highlights
Sanchez is affiliated with the University of Colorado, where he continues to advance his research in immunology. His work has garnered attention for its potential to improve treatment outcomes for chronic diseases and vaccine efficacy.
Collaborations
Some of his notable coworkers include Ross M Kedl and Catherine Haluszczak, who contribute to the collaborative efforts in his research endeavors.
Conclusion
Phillip J Sanchez's innovative work in immunology exemplifies the impact of scientific research on healthcare. His patents reflect a commitment to developing effective treatments for chronic diseases and enhancing vaccine responses.